Popular on TelAve
- Althea Gibson Honored as Final Release in U.S. Mint's American Women Quarters Program - 171
- BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
- Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
- Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
- How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
- Kudosity appoints Jules Holden to drive channel growth and expand offering in ecommerce and retail
- Nebraska and Starlink Local Installers working together for reliable internet
- Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
- Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
- Introducing TimelyTAXES™: A High-Speed, In-House Tax Engine Built for Telecom
Similar on TelAve
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
VALFIX Medical Inc. Announces the Issuance of a New U.S. Patent for Its Mitral Valve Repair Technology
TelAve News/10823297
VALFIX Medical is developing a trans-catheter solution for patients suffering from valvular heart disease and heart failure.
DOVER, Del. - TelAve -- VALFIX Medical Inc. announces the issuance of a new patent by its Israeli subsidiary VALFIX Medical Ltd. The new Patent US 11,931,021 B2 is titled "Anchors and locks for percutaneous valve implants".
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on TelAve News
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on TelAve News
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
Source: Valfix medical Inc.
0 Comments
Latest on TelAve News
- Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
- A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- Creative Investment Research Warns AT&T Rollback Undermines Market Integrity
- TimelyBill at ITEXPO 2026: Modern Billing for Modern Telecom
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi